Brand Name: Persona Revision Product Name: Persona Revision Trabecular Metal Femoral Distal Augment Recall
Brand Name: Persona Revision Product Name: Persona Revision¿ Trabecular Metal¿ Femoral Distal Augment Model/Catalog Number: 42-5572-066-10 Software Version: N/A Product Description: Persona Revision¿ Trabecular Metal¿ Femoral Distal Augment Size 9, 9+ 10mm Thicknes Component: N/A
FDA recall Class II
Ongoing
FDA lists this Class II recall for Brand Name: Persona Revision Product Name: Persona Revision Trabecular Metal Femoral Distal Augment. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-2578-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- May 11, 2026
- FDA report date
- Jul 1, 2026
- Quantity in commerce
- 12
- Distribution
- See key details
- FDA cause
- Labeling Change Control
What is being recalled?
Brand Name: Persona Revision Product Name: Persona Revision Trabecular Metal Femoral Distal Augment Model/Catalog Number: 42-5572-066-10 Software Version: N/A Product Description: Persona Revision Trabecular Metal Femoral Distal Augment Size 9, 9+ 10mm Thicknes Component: N/A
Affected model & UDI checker
Search the exact identifiers published for Z-2578-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| 42-5572-066-10 | Brand Name: Persona Revision Product Name: Persona Revision Trabecular Metal Femoral Distal Augment | Check source notice | Not specified |
| Not specified | Brand Name: Persona Revision Product Name: Persona Revision Trabecular Metal Femoral Distal Augment | Check source notice | 00889024561014 |
FDA code information
Lot Code: Model No. 42-5572-066-10 ; UDI-DI (01)00889024561014(17)331103(10)66232947 ; Lot number 66232947
Why was this product recalled?
Firm received a complaint with no clinical impact in which a posterior augment was found within the distal augment package.
What actions did Zimmer, Inc. take?
On May 11, 2026, the firm began notifying consignees via letters titled "URGENT MEDICAL DEVICE RECALL." Customers were instructed to review the notification and ensure affected personnel are aware of the contents. If you have affected product at your facility, assist your Zimmer Biomet sales representative and quarantine affected product. The sales representative will remove the affected product from your facility. If product has been further distributed, provide your customers with the recall notice and ensure documentation.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-2578-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 20, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 20, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology